Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

SciTech Development Awarded Foundation Grant for its ST-001 NanoFenretinide Technology

Wednesday, September 4, 2019   (0 Comments)
Posted by: Alisha Brown
Share |

(GROSSE POINTE FARMS, MI) August 13, 2019 – SciTech Development, a clinical stage drug development company, is pleased to announce that it has recently been awarded a foundation grant from a major, well-known cancer foundation for the scale-up, preparation and initiation of a Phase 1 clinical trial of ST-001 nanoFenretinide for the treatment of T-cell non-Hodgkin's lymphoma (NHL).

 

SciTech is currently seeking a Series A equity raise of approximately $15MM to bring its lead product ST-001 nanoFenretinide to market for the treatment of NHL and small cell lung cancer (SCLC). SciTech intends to use the grant for the scale-up, preparation and initiation of a Phase 1 clinical trial of ST-001 nanoFenretinide for the treatment of T-cell non-Hodgkin's lymphoma (NHL).

 

SciTech’s lead compound, ST-001 nanoFenretinide, is a small-molecule cancer drug employing a nanoparticle suspension for intravenous administration. ST-001 is comprised of fenretinide in a patented combination with carefully selected non-toxic phospholipids. SciTech’s product pipeline includes treatment for several other cancer indications.

 

The company has submitted an Investigational New Drug (IND) Application for ST-001 in the treatment of NHL. The FDA has already granted Orphan Drug Status for ST-001 in the treatment of two types of NHL: peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL). Information regarding SciTech’s nano formulation technology and oncology drug product ST-001 is available from SciTech Development, LLC by calling (313) 938-5517 or online at https://www.scitechdevelopment.com/


Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal